The new mineral, illoqite-(Ce), with the ideal formula Na2NaBaCeZnSi6O17, has been discovered in the Taseq Slope, Ilímaussaq Alkaline Complex, Southern Greenland. Illoqite-(Ce) occurs in a hyperalkaline ussingite vein closely related to one of the largest ussingite veins in the Ilímaussaq complex. The associated minerals are aegirine, arfvedsonite, a britholite-group mineral, epistolite, chkalovite, lueshite, Mn-rich pectolite group member and steenstrupine-(Ce). Illoqite-(Ce) crystallises as either single euhedral crystals up to 150 μm in size or radiating aggregates consisting of a few or many crystals. The aggregates are up to 200 μm in diameter. Illoqite-(Ce) can occur as scattered small groups of crystals or aggregates, but sometimes they occur in high concentrations creating clusters or bands almost completely consisting of illoqite-(Ce). The empirical formula on the basis of 17 anions is Na2.00Na1.00(Ba0.59Sr0.32Ca0.04Na0.03)Σ0.98(Ce0.68La0.31Nd0.09Pr0.04)Σ1.12(Zn0.42Fe0.34Li0.14Mn0.09)Σ0.99Si5.97O17, with the simplified formula being Na2Na(Ba,Sr)(Ce,La,Nd)(Zn,Fe,Li)Si6O17. Illoqite-(Ce) exhibits sector zoning between elements Sr and Ba. The crystal structure was determined using single-crystal X-ray diffraction data and refined to R1 = 2.46% using 1902 unique reflections. Illoqite-(Ce) is orthorhombic, Pcca, with a = 14.5340(7), b = 5.2213(1), c = 19.8270(4) Å, V = 1507.25(6) Å3 and Z = 4. The strongest lines of the powder X-ray diffraction pattern [d, Å (I, %) (hkl)] are: 7.266 (79) (200), 4.688 (44) (104), 4.241 (64) (210), 3.486 (79) (114), 3.340 (52) (312), 2.986 (67) (410), 2.882 (100) (314) and 2.789 (44) (016). Illoqite-(Ce) is a new member of the nordite supergroup and is named after the Greenlandic word illoq, meaning cousin, in allusion to the mineral's close relation to nordite-(Ce).

Psychiatric morbidity was measured in a prospective follow-up study of 51 patients admitted to hospital after minor head injury. By means of self report questionnaires (eg General Health Questionnaire (SHQ) and Impact of Event Scale), semistructured interviews and symptom-checklists, it was found that nearly half of the patients suffered considerable discomfort after 1 week. Improvement during the 3 months follow-up was generally poor. Both concussional symptoms and stress response contributed to the compromised well-being as measured by the GHQ, but outcome did not correlate to severity of injury. The GHQ-60 score of 1 week showed a strong positive correlation with outcome after 3 months. The incidence of post-traumatic stress disorder was low.

The study aimed at assessing stunting, wasting and breast-feeding as correlates of body composition in Cambodian children. As part of a nutrition trial (ISRCTN19918531), fat mass (FM) and fat-free mass (FFM) were measured using 2H dilution at 6 and 15 months of age. Of 419 infants enrolled, 98 % were breastfed, 15 % stunted and 4 % wasted at 6 months. At 15 months, 78 % were breastfed, 24 % stunted and 11 % wasted. Those not breastfed had lower FMI at 6 months but not at 15 months. Stunted children had lower FM at 6 months and lower FFM at 6 and 15 months compared with children with length-for-age z ≥0. Stunting was not associated with height-adjusted indexes fat mass index (FMI) or fat-free mass index (FFMI). Wasted children had lower FM, FFM, FMI and FFMI at 6 and 15 months compared with children with weight-for-length z (WLZ) ≥0. Generally, FFM and FFMI deficits increased with age, whereas FM and FMI deficits decreased, reflecting interactions between age and WLZ. For example, the FFM deficits were –0·99 (95 % CI –1·26, –0·72) kg at 6 months and –1·44 (95 % CI –1·69; –1·19) kg at 15 months (interaction, P<0·05), while the FMI deficits were –2·12 (95 % CI –2·53, –1·72) kg/m2 at 6 months and –1·32 (95 % CI –1·77, –0·87) kg/m2 at 15 months (interaction, P<0·05). This indicates that undernourished children preserve body fat at the detriment of fat-free tissue, which may have long-term consequences for health and working capacity.

The crystal structures of nine, and the chemical compositions of ten, natural samples of leucophanite, ideally NaCaBeSi2O6F, were investigated. The analysed samples display a large compositional variation with trace-element abundances >50,000 ppm, primarily due to rare earth elements (REE). Fromthese data, we propose a substitution scheme for the incorporation of REE for Ca, with additional Na substituting for Ca and the generation of vacancies to ensure charge balance. Compositional zonation was observed in some samples; this zonation correlates with variations in cathodoluminescence. The crystal structure of the nine analysed samples could all be refined in space group P212121. We found no evidence for a reduction of symmetry with increased trace-element concentration. Various twin combinations were observed and these seem related to crystallization conditions rather than structural or chemical factors.

The layered agpaitic nepheline syenites (kakortokites) of the Ilímaussaq complex, South Greenland, host voluminous accumulations of eudialyte-group minerals (EGM). These complex Na-Ca-zirconosilicates contain economically attractive levels of Zr, Nb and rare-earth elements (REE), but have commonly undergone extensive autometasomatic/hydrothermal alteration to a variety of secondary mineral assemblages. Three EGM alteration assemblages are recognized, characterized by the secondary zirconosilicates catapleiite, zircon and gittinsite. Theoretical petrogenetic grid models are constructed to assess mineral stabilities in terms of component activities in the late-stage melts and fluids. Widespread alteration of EGM to catapleiite records an overall increase in water activity, and reflects interaction of EGM with late-magmatic Na-, Cl- and F-rich aqueous fluids at the final stages of kakortokite crystallization. Localized alteration of EGM and catapleiite to the rare Ca-Zr silicate gittinsite, previously unidentified at Ilímaussaq, requires an increase in CaO activity and suggests post-magmatic interaction with Ca-Sr bearing aqueous fluids. The pseudomorphic replacement of EGM in the kakortokites was not found to be associated with significant remobilization of the primary Zr, Nb and REE mineralization, regardless of the high concentrations of potential transporting ligands such as F and Cl. We infer that the immobile behaviour essentially reflects the neutral to basic character of the late-magmatic fluids, in which REE-F compounds are insoluble and remobilization of REE as Cl complexes is inhibited by precipitation of nacareniobsite-(Ce) and various Ca-REE silicates. A subsequent decrease in F– activity would furthermore restrict the mobility of Zr as hydroxyl-fluoride complexes, and promote precipitation of the secondary zirconosilicates within the confines of the replaced EGM domains.

Bohseite is an orthorhombic calcium beryllium aluminosilicate with variable Al content and an endmember formula Ca4Be4Si9O24(OH4), that was discovered in the Piława Górna quarry in the eastern part of the Góry Sowie Block, ∼50 km southwest of Wrocław, SW Poland. It occurs in a zoned anatectic pegmatite dyke in close association with microcline, Cs-rich beryl, phenakite, helvite, 'lepidolite', probably bertrandite and unidentified Be-containing mica as alteration products after a primary Be mineral, probably beryl. Bohseite forms fan-like or parallel aggregates (up to 0.7 cm) of white, platy crystals (up to 2 mm long) with characteristic striations. It is white with a white streak, is translucent and has a vitreous lustre; it does not fluoresce under ultraviolet light. The cleavage is perfect on {001} and fair on {010}, and neither parting nor twinning was observed. Bohseite is brittle with a splintery fracture and Mohs hardness is 5–6. The calculated density is 2.719 g cm–3. The indices of refraction are α= 1.579, β = 1.580,γ = 1.597, all ±0.002; 2Vobs = 24(3)°, 2Vcalc = 27°; the optic orientation is as follows: X ^ a = 16.1°, Y ^ b = 16.1°, Z // c Bohseite shows orthorhombic diffraction symmetry, space group Cmcm, a = 23.204(6), b = 4.9442(9), c = 19.418(6) Å, V = 2227.7(4) Å3, Z = 4. The crystal structure was refined to an R1 value of 2.17% based on single-crystal data, and the chemical composition was determined by electron-microprobe analysis. Bohseite is isostructural with bavenite. Bohseite was originally approved with an end-member composition of Ca4Be3AlSi9O25(OH)3, but subsequent discovery of compositions with Be > 3.0 apfu led to redefinition of its end-member composition, holotype sample and locality, as reported here. There is extensive solid solution in bavenite–bohseite according to the scheme O(2)OH– + T(4)Si4+ + T(3)Be2+ ↔ O(2)O2– + T(4)Al3++ T(3)Si4+, and a general formula for the bavenite–bohseite minerals may be written as Ca4BexSi9Al4–xO28–x(OH)x, where x ranges from 2–4 apfu: Ca4Be2Si9Al2O26(OH)2 (bavenite) to Ca4Be4Si9O24(OH)4 (bohseite).

The new mineral hansesmarkite (IMA2015-067), Ca2Mn2Nb6O19·20H2O, was discovered at the AS Granit larvikite quarry in Tvedalen, Larvik, Vestfold, Norway. Hansesmarkite forms faintly yellow crystals up to 0.3 mm or thin coatingsin patches on gonnardite. Hansesmarkite is biaxial (+) with refractive indices (white light): α = 1.683(2), β = 1.698(2) and γ = 1.745(3); 2V(meas.) = 60.7(6)° and 2V(calc.) = 60.3°. The mineral exhibits moderate dispersion (r > v)and is pleochroic with X (almost colourless) < Y ( pale yellow) << Z (orangey yellow). The optical orientation is X ^ c = 20°, Y ^ b = 16° and Z ^ a = 5°. The empirical formula based on five electron probemicroanalyses and calculated based on Nb = 6 apfu is (Ca1.93Na0.02K0.01)∑1.96(Mn1.79Fe0.11)∑1.90Nb6O18.84·20H2O, with H2O determined from the structure solution.The mineral is triclinic, P1, with a = 9.081(4), b = 9.982(8), c = 10.60(1) Å, α = 111.07(8), β = 101.15(6), γ = 99.39(5)°, V = 850.8(13) Å3 and Z = 1. The structure was solved at 120 K because of thermalinstability of the mineral and refined to R1 = 2.50% for Fo > 4σ. The strongest reflections in the x-ray diffraction diagram are: [dobs. in Å (I)(hkl)] 9.282(36)(001), 8.610(100)(100, 011), 3.257(30)(031, 131)and 3.058(18)(130, 212). Hansesmarkite is the third naturally occurring hexaniobate in which six edge-sharing Nb-octahedra form the Lindqvist ion. These are linked via Mn-octahedra forming rods along [100] and Ca is located between the rods, creating a three dimensional structure via hydrogen bonds.

Bioelectrical impedance analysis (BIA) is an inexpensive, quick and non-invasive method to determine body composition. Equations used in BIA are typically derived in healthy individuals of European descent. BIA is specific to health status and ethnicity and may therefore provide inaccurate results in populations of different ethnic origin and health status. The aim of the present study was to test the validity of BIA in Ethiopian antiretroviral-naive HIV patients.

BIA was validated against the 2H dilution technique by comparing fat-free mass (FFM) measured by the two methods using paired t tests and Bland–Altman plots. BIA was based on single frequency (50 kHz) whole-body measurements. Data were obtained at three health facilities in Jimma Zone, Oromia Region, South-West Ethiopia. Data from 281 HIV-infected participants were available. Two-thirds were female and the mean age was 32·7 (sd 8·6) years. Also, 46 % were underweight with a BMI below 18·5 kg/m2. There were no differences in FFM between the methods. Overall, BIA slightly underestimated FFM by 0·1 kg (−0·1, 95 % CI −0·3, 0·2 kg). The Bland–Altman plot indicated acceptable agreement with an upper limit of agreement of 4·5 kg and a lower limit of agreement of −4·6 kg, but with a small correlation between the mean difference and the average FFM. BIA slightly overestimated FFM at low values compared with the 2H dilution technique, while it slightly underestimated FFM at high values. In conclusion, BIA proved to be valid in this population and may therefore be useful for measuring body composition in routine practice in HIV-infected African individuals.

Children with severe acute malnutrition (SAM) with complications require in-patient management including therapeutic feeding. Little attention has been given to the effects of these feeds on the essential fatty acid status of children with SAM. The objective of this study was to describe changes in the PUFA composition in whole blood in children with SAM during treatment and to determine predictors of change. This prospective study took place in a paediatric nutrition rehabilitation unit in Kampala, Uganda, and assessed whole-blood fatty acid composition of children with SAM at admission, transition, discharge and follow-up (8 and 16 weeks). ANCOVA was used to identify predictors of change in whole-blood PUFA. The study included 120 children with SAM and twenty-nine healthy control children of similar age and sex. Among the SAM children, 38 % were female and 64 % had oedema. Whole-blood n-6 PUFA proportions increased from admission to follow-up, except for arachidonic acid, which decreased by 0·79 (95 % CI 0·46, 1·12) fatty acid percentage (FA%) from admission to transition and 0·10 (95 % CI 0·23, 0·44) FA% at discharge. n-3 Long-chain (LC) PUFA decreased by 0·21 (95 % CI 0·03, 0·40) FA% at discharge and 0·22 (95 % CI 0·01, 0·42) FA% at 8 weeks of follow-up. This decrease was greater in children from families with recent fish intake and those with nasogastric tube feeding. Current therapeutic feeds do not correct whole-blood levels of LCPUFA, particularly n-3 LCPUFA, in children with SAM. Increased attention is needed to the contents of n-3 LCPUFA in therapeutic feeds.

Low-Se status may be associated with a higher risk of notably advanced prostate cancer. In a Danish population with a relatively low Se intake, we investigated the association between pre-diagnostic Se status and (1) the risk of total, advanced and high-grade prostate cancer and (2) all-cause and prostate cancer-specific mortality among men with prostate cancer. Within the Danish ‘Diet, Cancer and Health’ cohort, including 27 179 men, we identified 784 cases with incident prostate cancer through 2007. Each case was risk set-matched to one control. Two-thirds (n 525) of the cases had advanced disease at the time of diagnosis, and among these 170 had high-grade disease; 305 cases died (n 212 from prostate cancer) during follow-up through 2012. Plasma Se was not associated with total or advanced prostate cancer risk, but higher Se levels were associated with a lower risk of high-grade disease (HR 0·77; 95 % CI 0·64, 0·94; P=0·009). In survival analyses, a higher level of plasma Se was associated with a lower risk of all-cause (HR 0·92; 95 % CI 0·85, 1·00; P=0·04), but not prostate cancer-specific mortality. Higher levels of selenoprotein P were associated with a lower risk of high-grade disease (HR 0·85; 95 % CI 0·74, 0·97; P=0·01), but not with the risk of or mortality from advanced prostate cancer. In conclusion, levels of plasma Se and selenoprotein P were not associated with the risk of total and advanced prostate cancer, but higher levels of these two biomarkers were associated with a lower risk of high-grade disease.

We described levels of habitual physical activity and physical capacity in HIV patients initiating antiretroviral treatment in Ethiopia and assessed the role of HIV and nutritional indicators on these outcomes. Physical activity energy expenditure (PAEE) and activity levels were measured with combined heart rate and movement sensors. Physical capacity was assessed by grip strength, sleeping heart rate and heart rate economy. Grip strength data was also available from a sex- and age-matched HIV-negative reference group. Median PAEE was 27·9 (interquartile range 17·4–39·8) kJ/kg per day and mean±s.d. grip strength was 23·6 ± 6·7 kg. Advanced HIV disease predicted reduced levels of both physical activity and capacity; e.g. each unit viral load [log(1+copies/ml)] was associated with –15% PAEE (P < 0·001) and –1·0 kg grip strength (P < 0·001). Grip strength was 4·2 kg lower in patients compared to HIV-negative individuals (P < 0·001). Low body mass index (BMI) predicted poor physical activity and capacity independently of HIV status, e.g. BMI <16 was associated with −42% PAEE (P < 0·001) and −6·8 kg grip strength (P < 0·001) compared to BMI ⩾18·5. The study shows that advanced HIV and malnutrition are associated with considerably lower levels of physical activity and capacity in patients at initiation of antiretroviral treatment.